Chen Wei's team has made new progress in nebulized inhalation of the new crown vaccine

The reporter learned from the Academy of Military Medicine of the Academy of Military Sciences on the 28th that the phase I clinical trial data of the recombinant new crown vaccine (adenovirus vector) for nebulization developed by Chen Wei, an academician of the Chinese Academy of Engineering and a researcher of the Academy of Military Medicine, was held in Beijing.

The results of the study show that the recombinant new crown vaccine for aerosol inhalation has good safety, tolerability and immunogenicity

It is understood that the aerosol inhalation vaccine is the same as the recombinant new crown vaccine that has been conditionally approved for marketing in terms of formulation and production technology

According to researcher Hou Lihua of the Academy of Military Medicine of the Academy of Military Sciences, aerosolized inhalation vaccine can be vaccinated only by "inhalation", which is safer and more convenient, and is suitable for large-scale population promotion